You are here

  • Home
  • Archive
  • Volume 12, Issue 7
  • Correction: ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3

https://doi.org/10.1136/jitc-2023-007766corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Ao Y, Gao J, Jin C, et al. ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3. J ImmunoTher Cancer 2023;11:e007766. doi: 10.1136/jitc-2023-007766.

    This article has been corrected since it was first published. Labels have been added to Figure 5J to clarify the group information for each immunoblot band. From left to right, the three immunoblot bands represent IgG, IP, and IP, respectively.